SG11202105169WA - Transmembrane domain derived from human lrrc24 protein - Google Patents

Transmembrane domain derived from human lrrc24 protein

Info

Publication number
SG11202105169WA
SG11202105169WA SG11202105169WA SG11202105169WA SG11202105169WA SG 11202105169W A SG11202105169W A SG 11202105169WA SG 11202105169W A SG11202105169W A SG 11202105169WA SG 11202105169W A SG11202105169W A SG 11202105169WA SG 11202105169W A SG11202105169W A SG 11202105169WA
Authority
SG
Singapore
Prior art keywords
protein
transmembrane domain
domain derived
lrrc24
human
Prior art date
Application number
SG11202105169WA
Other languages
English (en)
Inventor
Seong Jun Kim
Kyun Do Kim
In Su Hwang
Keunbon Ku
Chonsaeng Kim
Bum Tae Kim
Dae Gyun Ahn
Hae Soo Kim
Young Chan Kwon
Original Assignee
Korea Res Inst Chemical Tech
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Korea Res Inst Chemical Tech filed Critical Korea Res Inst Chemical Tech
Priority claimed from PCT/KR2019/017829 external-priority patent/WO2020130547A1/ko
Publication of SG11202105169WA publication Critical patent/SG11202105169WA/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/385Haptens or antigens, bound to carriers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K19/00Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08Peptides having 5 to 11 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • A61K47/645Polycationic or polyanionic oligopeptides, polypeptides or polyamino acids, e.g. polylysine, polyarginine, polyglutamic acid or peptide TAT
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/60Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031Proteins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/01Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/03Fusion polypeptide containing a localisation/targetting motif containing a transmembrane segment
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/60Fusion polypeptide containing spectroscopic/fluorescent detection, e.g. green fluorescent protein [GFP]
SG11202105169WA 2018-12-19 2019-12-16 Transmembrane domain derived from human lrrc24 protein SG11202105169WA (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR20180165438 2018-12-19
KR1020190144779A KR102351041B1 (ko) 2018-12-19 2019-11-13 인간 lrrc24 단백질 유래 세포막 투과 도메인
PCT/KR2019/017829 WO2020130547A1 (ko) 2018-12-19 2019-12-16 인간 엘알알씨24 단백질 유래 세포막 투과 도메인

Publications (1)

Publication Number Publication Date
SG11202105169WA true SG11202105169WA (en) 2021-06-29

Family

ID=71401249

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202105169WA SG11202105169WA (en) 2018-12-19 2019-12-16 Transmembrane domain derived from human lrrc24 protein

Country Status (10)

Country Link
US (1) US20220306718A1 (ko)
EP (1) EP3875113A4 (ko)
JP (1) JP7193633B2 (ko)
KR (1) KR102351041B1 (ko)
CN (1) CN113166216A (ko)
AU (1) AU2019403533A1 (ko)
BR (1) BR112021012019A2 (ko)
CA (1) CA3122428A1 (ko)
PH (1) PH12021551150A1 (ko)
SG (1) SG11202105169WA (ko)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102484312B1 (ko) * 2020-05-14 2023-01-02 한국화학연구원 고효능 사스 코로나바이러스 2 항원 및 이를 포함하는 백신 조성물

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004020595A2 (en) * 2002-08-29 2004-03-11 Five Prime Therapeutics, Inc. Novel human polypeptides encoded by polynucleotides
WO2010129033A2 (en) * 2009-04-29 2010-11-11 Calmune Corporation Modified antibodies for passive immunotherapy
EP2821486B1 (en) 2012-02-27 2018-12-26 Riken Method of introducing nucleic acid into plant cells
US10967000B2 (en) * 2012-07-11 2021-04-06 Gemvax & Kael Co., Ltd. Cell-penetrating peptide, conjugate comprising same and composition comprising same
KR102166542B1 (ko) * 2012-09-28 2020-10-16 주식회사 젬백스앤카엘 줄기세포 검출을 위한 텔로머라제 유래 펩티드 및 조영물질의 컨쥬게이트 및 이를 포함하는 조영제
TR201905612T4 (tr) * 2012-12-05 2019-05-21 Univ Heidelberg Ruprecht Karls Proteinlerin ve çok değerlikli, hücreye nüfuz eden peptitlerin konjugatları ve bunların kullanımları.
WO2014099671A1 (en) * 2012-12-20 2014-06-26 Bluebird Bio, Inc. Chimeric antigen receptors and immune cells targeting b cell malignancies
US20180133327A1 (en) * 2015-03-16 2018-05-17 Amal Therapeutics Sa Cell Penetrating Peptides and Complexes Comprising the Same
CA2981716C (en) * 2015-04-10 2022-04-12 Feldan Bio Inc. Polypeptide-based shuttle agents for improving the transduction efficiency of polypeptide cargos to the cytosol of target eukaryotic cells, uses thereof, methods and kits relating to same
CN105112383B (zh) * 2015-08-25 2018-12-14 三峡大学 细胞膜穿透肽hPP5及其用途
CN105175526B (zh) * 2015-08-25 2018-08-14 三峡大学 细胞膜穿透肽hPP8及其用途
ES2962588T3 (es) * 2016-03-23 2024-03-20 Helmholtz Zentrum Muenchen Deutsches Forschungszentrum Gesundheit & Umwelt Gmbh Proteínas de fusión de PD-1 y 4-1BB
KR101848147B1 (ko) * 2016-07-14 2018-04-11 건양대학교산학협력단 세포 투과성 hoxa9 융합단백질 및 이를 포함하는 폐암의 예방 또는 치료용 조성물
IL249610A (en) * 2016-12-15 2017-12-31 Nat Inst Biotechnology Negev Ltd Chimeric proteins for cancer treatment

Also Published As

Publication number Publication date
JP2022510309A (ja) 2022-01-26
EP3875113A1 (en) 2021-09-08
KR102351041B1 (ko) 2022-01-13
BR112021012019A2 (pt) 2021-11-03
AU2019403533A1 (en) 2021-06-24
CA3122428A1 (en) 2020-06-25
EP3875113A4 (en) 2022-08-31
US20220306718A1 (en) 2022-09-29
JP7193633B2 (ja) 2022-12-20
CN113166216A (zh) 2021-07-23
PH12021551150A1 (en) 2021-11-03
KR20200076582A (ko) 2020-06-29

Similar Documents

Publication Publication Date Title
IL279505A (en) Chimeric transmembrane protein and its uses
IL274842A (en) A substitute for cream containing protein from leguminous grains
IL281804A (en) Protein purification methods
AU201815218S (en) Chair
AU201815210S (en) Chair
DK3737402T3 (en) Modificeret protein
GB201711481D0 (en) Protein purification
AU201815213S (en) Chair
AU201813716S (en) Chair
EP3898217C0 (en) PAPER TISSUE PRODUCT
IL279355A (en) Antigen binding protein against STEAP1
GB201819434D0 (en) Domain adaptation
IL273898B2 (en) A vesicle-adsorbing transmembrane protein
ZA201906029B (en) Novel insect inhibitory proteins
IL278839A (en) Sewing system
GB201701438D0 (en) Skine tissue
SG11202105169WA (en) Transmembrane domain derived from human lrrc24 protein
EP3401324A4 (en) NEW DOMAIN OF PROTEIN TRANSDUCTION AND USE THEREOF
IL283212A (en) Anti-waste sanitary system
IL277747B (en) Sewing system
GB2612914B (en) Tissue analysis
GB2592507B (en) Forceps
GB201819164D0 (en) Artificial-intelligence-assisted surgery
EP3615561C0 (en) VARIANTS OF HUMAN BMP7 PROTEIN
IL290368A (en) Altered human variable regions